XML 78 R68.htm IDEA: XBRL DOCUMENT v3.23.4
Equity Offerings (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Jul. 05, 2023
Jan. 09, 2023
Feb. 08, 2022
Jul. 24, 2023
Jul. 31, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2023
Jul. 03, 2023
Common stock, weighted average exercise price   $ 3.00              
Repriced warrants               $ 300,000  
Fair value of Series E warrant               $ 1,900,000  
Common stock reserve for issuance             11,042,151,000 11,042,151,000  
Weighted average exercise price               $ 5.31  
Deemed dividend amount             $ 0 $ 800,000  
Minimum [Member] | Existing warrants. | Warrant inducement offer.                  
Warrants issued price per share   14.00              
Maximum [Member] | Existing warrants. | Warrant inducement offer.                  
Warrants issued price per share   $ 526.50              
Warrant Repricing [Member]                  
Expected term (In Years)               4 years 7 months 6 days  
Risk-free interest rate               2.87%  
Expected Volatility               98.90%  
Valuation of warrants               $ 400,000  
Fee withheld   $ 200,000              
Stock issued during period, warrants exercised   331,608,000              
Warrants issued price per share   $ 4.00              
Proceeds from issuance of common stock   $ 1,300,000              
Private Placement [Member]                  
Common stock issued (in shares) 1,093,552,000     546,776,000          
Offering [Member]                  
Common stock issued (in shares)     190,700,000            
Expected term (In Years)               5 years  
Expected dividend yield               0.00%  
Risk-free interest rate               1.81%  
Expected Volatility               93.25%  
Valuation of warrants               $ 400,000  
Fee withheld               1,100,000  
Stock issued during period, warrants exercised         800,000 1,000,000      
Offering expenses paid or payable               1,800,000  
Proceeds from issuance of common stock               11,500,000  
Offering [Member] | Accrued Expenses [Member]                  
Cash fee for placement agent             $ 900,000 $ 900,000  
Overallotment Option [Member]                  
Overallotment option period     45 years            
Common stock issued (in shares)     24,902,000            
Overallotment Option [Member] | Maximum [Member]                  
Common stock issued (in shares)     72,000,000            
Series A Warrants [Member]                  
Percentage of shares exercised   9.99%              
Stock issued during period, warrants exercised   497,908,000              
Par value   $ 0.0001              
Warrants issued price per share   $ 3.00              
Offering expenses paid or payable   $ 1,000,000              
Proceeds from issuance of common stock   $ 900,000              
Series A Warrants [Member] | Offering [Member]                  
Common stock issued (in shares)     480,052,000            
Equity offering description     warrants to purchase one share of common stock            
Stock issued during period, warrants exercised         800,000        
Warrants issued price per share     $ 25.00            
Series A Warrants [Member] | Overallotment Option [Member]                  
Common stock issued (in shares)     72,000,000            
Series A Warrants [Member] | Overallotment Option [Member] | Maximum [Member]                  
Common stock issued (in shares)     72,000,000            
Series B Warrants [Member]                  
Stock issued during period, warrants exercised   7,203,000              
Warrants issued price per share   $ 3.00              
Offering expenses paid or payable   $ 1,000,000              
Proceeds from issuance of common stock   7,100,000              
Series B Warrants [Member] | Offering [Member]                  
Common stock issued (in shares)     480,052,000            
Equity offering description     warrants to purchase one share of common stock            
Warrants issued price per share     $ 25.00            
Series B Warrants [Member] | Overallotment Option [Member]                  
Common stock issued (in shares)     72,000,000            
Series B Warrants [Member] | Overallotment Option [Member] | Maximum [Member]                  
Common stock issued (in shares)     72,000,000            
Series A convertible preferred stock [Member] | Private Placement [Member]                  
Convertible preferred stock 1,750,000               546,776,000
Approximately Common Stock             625,000 625,000  
Conversion of outstanding common stock       875,000          
Pre-funded Warrants. | Offering [Member]                  
Common stock issued (in shares)     289,352,000            
Equity offering description     warrants to purchase one share of common stock            
Stock issued during period, warrants exercised           289,352,000      
Warrants issued price per share     $ 0.005            
Series A and Series B Warrants. | Offering [Member]                  
Valuation of warrants     $ 11,600,000            
Series F and Series G Warrants. | Private Placement [Member]                  
Valuation of warrants   $ 5,500,000              
Series A warrants and Series B warrants. | Offering [Member]                  
Stock issued during period, warrants exercised           500,000      
Common Stocks | At The Market Offerings.                  
Common stock issued (in shares)   331,608,000              
Warrants issued price per share   $ 4.00              
Net proceeds   $ 1,100,000              
Securities Purchase AgreeMent Class B [Member] | Series A convertible preferred stock [Member] | Private Placement [Member]                  
Common stock issued (in shares)   4,501,060,000